Medyria AG

Medyria has developed a unique technology for the direct measurement of the Blood Flow Velocity (BFV) and is developing medical devices that integrates the BFV sensor.
Recently we started the development of the PyCath, the only microcatheter on the planet earth that allows the full assessment of the heart physiology with a direct blood flow velocity measurement. This has a huge benefit for all patients, because completes the common coronary coronary study with an assessment of the microcirculation, bringing the eligibility of angina pectoris patients from 50% to 100%.
Besides this main project Medyria offers its sensing technology though an OEM business model that is successfully leading to the development of new cardiovascular devices functioning on the BFV measurement.